ClassID:

96911

C07K14/4717 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Plasma globulins, lactoglobulin

Recent Application in this class:
#1
20260108590
2026-04-23

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

#2
20260098068
2026-04-09

GC-GLOBULIN FOR USE IN TREATING DIABETES

#3
20260098057
2026-04-09

CRYSTALLISATION OF A PROTEIN CAPABLE OF CRYSTALLIZING UNDER SALTING-IN CONDITIONS USING MULTIPLE PROTEIN FEEDS

#4
20260061041
2026-03-05

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

#5
20260049127
2026-02-19

METHODS TO PRODUCE A HUMAN PLASMA-DERIVED IGG PREPARATION ENRICHED IN BRAIN DISEASE-RELATED NATURAL IGGS

#6
20260041124
2026-02-12

PH NEUTRAL BETA-LACTOGLOBULIN BEVERAGE PREPARATION

#7
20260022148
2026-01-22

CHIMERIC CASEIN AND WHEY PROTEINS AND USE THEREOF

#8
20260008825
2026-01-08

A NOVEL PROTEIN COMPOSITION AND THEIR USE IN FORMULATING DAIRY PRODUCTS

#9
20250230208
2025-07-17

METHODS FOR TREATING EYE DISEASES USING LIPID BINDING PROTEIN-BASED COMPLEXES

#10
20250206788
2025-06-26

CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF

#11
20250145661
2025-05-08

TARGET MOLECULE REDUCTION METHOD, REDUCTION DEVICE, AND ELECTRODE

#12
20250107546
2025-04-03

MICROPARTICULATION OF RECOMBINANT BETA-LACTOGLOBULIN AND ASSOCIATED FOOD APPLICATIONS

#13
20250017239
2025-01-16

ACIDIC BETA-LACTOGLOBULIN BEVERAGE PREPARATION

#14
20240352091
2024-10-24

ANIMAL FREE- ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN FUSION MILK PROTEINS AND A PROCESS FOR PREPARING THE SAME

#15
20240307439
2024-09-19

MULTIFUNCTIONAL IMMUNE CELL THERAPIES

#16
20240294589
2024-09-05

RECOMBINANT PROTEINS

#17
20240200095
2024-06-20

PROMOTERS

#18
20240199712
2024-06-20

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

#19
20240035041
2024-02-01

CHEESE FOOD COMPOSITIONS

#20
20240034759
2024-02-01

IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

#21
20240026311
2024-01-25

ARTIFICIALLY SYNTHESIZED mRNA AND USE OF SAME

#22
20230371547
2023-11-23

COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME

#23
20230348860
2023-11-02

Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use

#24
20230321737
2023-10-12

QUICK CLICK SAW ASSEMBLY

#25
20230128472
2023-04-27

Compositions and methods for treating hemoglobinopathies

#26
20230106635
2023-04-06

HYPOALLERGENIC RECOMBINANT MILK PROTEINS AND COMPOSITIONS COMPRISING THE SAME

#27
20230097644
2023-03-30

ULTRASOUND-ASSISTED SIMULATED DIGESTION METHOD OF CASEIN ACTIVE PEPTIDE AND APPLICATION THERE OF IN HEALTH FOODS

#28
20220370575
2022-11-24

Compositions and methods for treating hemoglobinopathies

#29
20220298514
2022-09-22

AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY

#30
20220228110
2022-07-21

Methods for screening host cells expressing target proteins

#31
20220211061
2022-07-07

RECOMBINANT MILK PROTEINS AND COMPOSITIONS COMPRISING THE SAME

#32
20220202048
2022-06-30

PH NEUTRAL BETA-LACTOGLOBULIN BEVERAGE PREPARATION

#33
20220195000
2022-06-23

PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES

#34
20220192214
2022-06-23

Acidic beta-lactoglobulin beverage preparation

#35
20220169690
2022-06-02

RECOMBINANT MILK PROTEINS AND FOOD COMPOSITIONS COMPRISING THE SAME

#36
20220117258
2022-04-21

Compositions comprising a casein and methods of producing the same

#37
20220098259
2022-03-31

RECOMBINANT MILK PROTEINS

#38
20210317468
2021-10-14

SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS

#39
20210261955
2021-08-26

Compositions and methods for treating hemoglobinopathies

#40
20210252118
2021-08-19

Compositions and methods for treating hemoglobinopathies

#41
20210222186
2021-07-22

MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS

#42
20210180024
2021-06-17

Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use

#43
20210054058
2021-02-25

METHODS TO PRODUCE A HUMAN PLASMA-DERIVED IGG PREPARATION ENRICHED IN BRAIN DISEASE-RELATED NATURAL IGGS

#44
20210037849
2021-02-11

COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME

#45
20210037848
2021-02-11

COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME

#46
20210010017
2021-01-14

FOOD COMPOSITIONS COMPRISING MILK PROTEINS PRODUCED IN TRANSGENIC PLANTS

#47
20200399331
2020-12-24

Curcumin-peptide conjugates and formulations thereof

#48
20200352205
2020-11-12

Production of protein-polysaccharide conjugates

#49
20200317742
2020-10-08

Immunogenic peptides and their use in immune disorders

#50
20200297762
2020-09-24

Methods and compositions for targeted cleavage and recombination

#51
20200231699
2020-07-23

T-cells expressing anti-LIV1 chimeric antigen receptor

#52
20200157142
2020-05-21

Ultrasound-assisted simulated digestion method of milk protein active peptide and application thereof in health foods

#53
20200123556
2020-04-23

MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS

#54
20190161524
2019-05-30

Alpha-1-microglobulin derived proteins and their use

#55
20190062556
2019-02-28

Protein-surfactant-monomer/polymer blends and copolymers for protein-based plastics

#56
20190038712
2019-02-07

Methods of treatment using hemopexin compositions

#57
20190002906
2019-01-03

Synthesis and structure of high potency RNA therapeutics

#58
20180334483
2018-11-22

Electrically conductive protein nanofibers and biofilms

#59
20180271111
2018-09-27

Compositions comprising a casein and methods of producing the same

#60
20180223313
2018-08-09

Lentiviral protein delivery system for RNA-guided genome editing

#61
20180172700
2018-06-21

Affinity Plate for Haptoglobin Phenotype Determination, Kit Comprising It, and Method of Haptoglobin Phenotype Determination by Means of Affinity Plates in Combination with Desorption Ionization Mass Spectrometry Techniques

#62
20180135074
2018-05-17

RECOMBINANT AAV VECTORS FOR GENE THERAPY OF HUMAN HEMATOPOIETIC DISORDERS

#63
20180051262
2018-02-22

Messenger UNA molecules and uses thereof

#64
20180051045
2018-02-22

Ruthenium-sphingomyelin complexes and methods for their use in the treatment of tumors

#65
20170326174
2017-11-16

Methods and compositions for targeted cleavage and recombination

#66
20170318835
2017-11-09

METHOD FOR SEPARATING ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN

#67
20170314054
2017-11-02

Identification of transglutaminase substrates and uses therefor

#68
20170273328
2017-09-28

Compositions comprising a casein and methods of producing the same

#69
20170246372
2017-08-31

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION AND TREATING CONDITIONS

#70
20170218051
2017-08-03

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs

#71
20170072011
2017-03-16

Methods of treatment using hemopexin compositions

#72
20170049141
2017-02-23

PRODUCTION OF PROTEIN-POLYSACCHARIDE CONJUGATES

#73
20160194367
2016-07-07

Immunogenic peptides and their use in immune disorders

#74
20160130567
2016-05-12

MESSENGER UNA MOLECULES AND USES THEREOF

#75
20160113852
2016-04-28

Sex hormone-binding globulin for use as a medicament

#76
20160017013
2016-01-21

Use of mutant haptoglobin having angiogenesis promoting activity

#77
20150320878
2015-11-12

Curcumin-peptide conjugates and formulations thereof

#78
20150079194
2015-03-19

Systems, compositions, and methods for transplantation and treating conditions

#79
20140369980
2014-12-18

Methods and compositions for targeted cleavage and recombination

#80
20140271679
2014-09-18

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

#81
20140271669
2014-09-18

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

#82
20140223588
2014-08-07

A2M FRAGMENTS AND APPLICATIONS THEREOF

#83
20140094411
2014-04-03

Method of purifying proteins

#84
20140086885
2014-03-27

Methods and compositions for targeted cleavage and recombination

#85
20130101548
2013-04-25

Whey protein isolate hydrogels and their uses

#86
20130004490
2013-01-03

DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER'S DISEASE

#87
20120093933
2012-04-19

Denatured lactoglobulin and polyphenol coassemblies

#88
20110104190
2011-05-05

Modified beta-lactoglobulins for immunotherapy of milk allergy

#89
20110030076
2011-02-03

Methods and compositions for targeted cleavage and recombination

#90
20100303866
2010-12-02

Immunogenic peptides and their use in immune disorders

#91
20090311407
2009-12-17

Production of protein-polysaccharide conjugates

#92
20090297545
2009-12-03

IMMUNOMODULATORY DAIRY PEPTIDES AND USES THEREOF

#93
20090281282
2009-11-12

Method for the isolation of haptoglobin

#94
20090075904
2009-03-19

Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use

#95
20080070828
2008-03-20

Ace-Inhibitory Whey Hydrolysates

#96
20060216330
2006-09-28

Peptides having an ace inhibiting effect

#97
20060105323
2006-05-18

Multi-reporter gene model for toxicological screening

#98
20050203285
2005-09-15

Filtration

#99
20050155092
2005-07-14

Desmin gene having novel point mutation causative of dilated cardiomyopathy

#100
20050064474
2005-03-24

Methods and compositions for targeted cleavage and recombination

#101
17326785
2021-10-12

Recombinant milk proteins

#102
17039760
2021-01-19

Recombinant milk proteins